The iconic rise of Viagra has long been a example of pharmaceutical success, but its position within the broader industry now presents questions about potential returns . Alternative versions are undercutting exclusivity , prompting worries that supporting companies closely tied to Viagra's previous position could be a dangerous strategy, especiall